drTPH Profile Banner
Tim van de Hoef Profile
Tim van de Hoef

@drTPH

Followers
94
Following
18
Media
0
Statuses
29

Interventional Cardiologist at University Medical Center Utrecht

Utrecht, Nederland
Joined March 2013
Don't wanna be here? Send us removal request.
@drTPH
Tim van de Hoef
@drTPH
3 years
RT @EuroInterventio: This study shows that coronary microvascular dysfunction, identified only by an impaired coronary flow reserve, was as….
0
23
0
@drTPH
Tim van de Hoef
@drTPH
4 years
RT @SDRoyMD: Summary of late-breaking clinical trials and science at #TCT2021. @crfheart @TCTMD .#ACCFIT #AHAFIT #ACCIC #ACCEarlyCareer htt….
0
58
0
@drTPH
Tim van de Hoef
@drTPH
4 years
RT @JEscaned: An analysis of the TWILIGHT-HBR substudy by @ANazmiCalik @elif_ilkay9 published at @PCRonline .@shci_….
0
6
0
@drTPH
Tim van de Hoef
@drTPH
4 years
RT @MGtberg: iFR and FFR with similar outcome at 5-years! No difference in any subgroup or components of the composite outcome. “iFR is qui….
0
46
0
@drTPH
Tim van de Hoef
@drTPH
4 years
RT @drandrewsharp: Coronary Physiology Strikes Back?! ILIAS Registry shows that FFR guidance may be strengthened by the addition of coronar….
0
10
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @DrArgyle: Event rates 1/2 w/ #iFR deferral vs #FFR per @jerd10 in LAD & #ACS
Tweet media one
Tweet media two
0
5
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @drandrewsharp: Wow, this chap appears to have read the #ORBITA paper, the appendix and the refs, as well as the abstract, other tweets….
0
2
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @CMichaelGibson: ORBITA trial: PCI significantly reduced ischemia but no improvement in exercise time compared to placebo procedure #TCT….
0
27
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @CMichaelGibson: Dr. Al-Lamee explains ORBITA: rand, sham-cntrl trial of PCI in pts w/CAD watch full interview here .
0
20
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @CMichaelGibson: Dr. Al - Lamee discusses results of ORBITA Trial in this mornings press conference #TCTCDenver
Tweet media one
0
7
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @drandrewsharp: #ORBITA #tctdenver
Tweet media one
0
5
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @bmj_latest: A substantial percentage of US journal editors received personal payments from industry and these payments were often large….
0
297
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @drandrewsharp: #orbita giant Rasha.
Tweet media one
0
6
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @mmamas1973: Can't be right that 8 fold difference between operators for #radialfirst approach in STEMI. Not right for patients https://….
0
9
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @NL_heart: The call for the 2018 Einthoven dissertation prizes is open. Deadline 5-1-2018. Check our website for….
0
4
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @SukhNijjer: Here’s a clearer picture. Deferring lesions in the LAD using FFR is associated with a doubling in clinical events compared….
0
11
0
@drTPH
Tim van de Hoef
@drTPH
8 years
RT @angioplastyorg: DARE > Drug-eluting balloon non-inferior to DES for ISR. Only available in Europe; FDA has not yet approved DEB for cor….
0
8
0
@drTPH
Tim van de Hoef
@drTPH
10 years
RT @DrSethdb: #OnThisDay 1977 38 yrs .1st ever balloon angioplasty of coronary artery.beginning of #PCI. http://t.co/c4cbCe9W4S http://t.co….
0
50
0
@drTPH
Tim van de Hoef
@drTPH
11 years
RT @UNICEF: Thank you Jonas Salk, born 100 years ago today, who refused to patent #polio vaccine http://t.co/LZAEunmk7y #endpolio http://t.….
0
3K
0
@drTPH
Tim van de Hoef
@drTPH
11 years
RT @cardiobrief: Corrected Link: Dutch Investigation Finds Serious Flaws In Influential New England Journal Of Medicine Study http://t.co/U….
0
4
0